Maraviroc 150 Mg Daily Plus Lopinavir/Ritonavir, a Nucleoside/Nucleotide Reverse Transcriptase Inhibitor-Sparing Regimen for HIV-infected Naive Patients: 48-Week Final Results of VEMAN Study

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2014.12.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy of a Nucleoside-Sparing Regimen of Darunavir/Ritonavir Plus Raltegravir in Treatment-Naive HIV-1-infected Patients (ACTG A5262)

AIDS
Infectious DiseasesAllergyImmunology
2011English

Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients

AIDS Research and Treatment
ImmunologyPublic HealthAllergyEnvironmentalDermatologyInfectious DiseasesOccupational Health
2015English

Multicenter Study of Skin Rashes and Hepatotoxicity in Antiretroviral-Naïve HIV-positive Patients Receiving Non-Nucleoside Reverse-Transcriptase Inhibitor Plus Nucleoside Reverse-Transcriptase Inhibitors in Taiwan

PLoS ONE
Multidisciplinary
2017English

HIV-1 Reverse Transcriptase Nucleotide Substitutions in Subtype C–Infected, Drug-Naive, and Treatment-Experienced Patients in South India

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2011English

Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients With Nucleoside Reverse Transcriptase Inhibitor Resistance

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2018English

Fosamprenavir or Atazanavir Once Daily Boosted With Ritonavir 100mg, Plus Tenofovir/Emtricitabine, for the Initial Treatment of HIV Infection: 48-Week Results of ALERT

AIDS Research and Therapy
VirologyMolecular MedicinePharmacology
2008English

Nucleoside Reverse Transcriptase Inhibitor Usage and the Incidence of Peripheral Neuropathy in HIV/AIDS Patients

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
2003English

96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

Development of a Vaginal Delivery Film Containing EFdA, a Novel Anti-Hiv Nucleoside Reverse Transcriptase Inhibitor

International Journal of Pharmaceutics
Pharmaceutical Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy